Evaluation of recurrent miscarriage
Summary
Recurrent miscarriage is defined by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine as 2 or more failed clinical pregnancies (i.e., documented by ultrasound or histopathology).[1][2] It affects about 1% of all fertile couples trying to conceive, in comparison with sporadic nonconsecutive miscarriages, which occur in about 15% to 20% of all pregnancies.[3][4] A miscarriage includes any pregnancy that ends before the age of viability, which currently stands at 24 weeks' gestation. A miscarriage that occurs before 12 weeks' gestation is commonly termed an early or first-trimester miscarriage, and one that occurs between 13 and 24 weeks' gestation is known as a late or second-trimester miscarriage.
Evaluation can start after 2 or 3 consecutive miscarriages, as prevalence of causes is similar in those with 2, 3, or more miscarriages.[5][6] Despite a wide range of investigations, no apparent cause is found in >50% of cases of recurrent miscarriage.[7] About 70% of patients with no cause found will achieve a live birth in the subsequent pregnancy depending on the age of the woman and the number of previous miscarriages.[5][7][Figure caption and citation for the preceding image starts]: Predicted percentage success rate of subsequent pregnancy according to age and previous miscarriage historyCreated by the BMJ Group; data from Brigham SA, et al. Hum Reprod. 1999;14:2868-2871 [Citation ends].
Definite associations of recurrent miscarriage include chromosomal abnormalities, antiphospholipid syndrome, certain structural uterine abnormalities such as septate uterus, and certain thrombophilias. However, a reduction in risk of miscarriage in a subsequent pregnancy following treatment has not been proven unequivocally for most of these conditions. Controversy surrounds the possible association of other conditions with recurrent miscarriage, including immunologic factors, other uterine abnormalities (e.g., cervical insufficiency), infection, and male and endocrinologic factors. There is a need for high-quality and methodologically sound research to guide management of these patients.[8]
Risk factors
Increasing maternal age reduces the chance of a successful live birth. Women ages 20 years with 2 previous miscarriages have a 92% chance of success in the next pregnancy compared with only a 60% chance of success in women ages 45 years with 2 previous miscarriages.[9]
Advanced paternal age also appears to be associated with greater risk for spontaneous miscarriage.[10][11][12] Increased frequency of chromosomal anomalies in sperm has been implicated.[13] In one systematic review and meta-analysis, risk for pregnancy loss <20 weeks was increased by 23% and 43% among men ages 40-44 and ≥45 years, respectively (compared with men ages 25-29 years).[12]
Primigravidas and patients who consistently have successful pregnancies have only about 5% risk of miscarriage, compared with 24% in patients who have previously miscarried.[14] Other studies similarly show a trend of miscarriage rate increasing with the number of previous miscarriages.[9][15] Therefore, the risk of miscarriage is directly related to the outcome of previous pregnancies.
Recurrent miscarriage is a stressful condition, so alongside medical investigations and appropriate treatment, patient education, counseling, and support should be provided.
Diferenciales
Común
- Idiopathic recurrent miscarriage
- Fetal chromosomal abnormality
- Chronic endometritis
Infrecuente
- Parental chromosomal abnormality
- Antiphospholipid syndrome
- Cervical insufficiency
- Uncontrolled diabetes mellitus
- Uncontrolled thyroid dysfunction
- Thrombophilias
- Uterine abnormalities (e.g., bicornuate, septate, or arcuate uterus)
- Bacterial vaginosis
- Polycystic ovarian syndrome (PCOS)
- Smoking, caffeine intake
Colaboradores
Autores
Winifred Mak, MD, PhD
Associate Professor
Women's health
Dell Medical School
University of Texas
Austin
Department of Reproductive Endocrinology and Infertility
University of Texas Health Science Center at San Antonio
San Antonio
TX
Divulgaciones
WM declares that she has received grants from NIH to study the role of sperm in recurrent pregnancy loss. She has served as a grand round speaker at Yale School of Medicine (Obstetrics and Gynecology), and as a postgraduate course speaker for the American Society of Reproductive Medicine.
Agradecimientos
Dr Winifred Mak would like to gratefully acknowledge Dr Ai-Wei Tang and Dr Siobhan Quenby, the previous contributors to this topic. AT declares that she has no competing interests. SQ is an author of a reference cited in this topic. SQ declares that she has no competing interests.
Revisores por pares
MaryEllen Pavone, MD, MSCI
Professor of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility
Northwestern University
Evanstan
IL
Divulgaciones
MP declares that she has no competing interests.
Sacha Krieg, MD, PhD
Associate Professor of Reproductive Endocrinology and Infertility
Oregon Health and Science University
Portland
OR
Divulgaciones
SK declares that she has no competing interests.
Justin C. Konje, MBBS, FMCOG, MRCOG, FWACS, MD, MBA
Professor of Obstetrics and Gynaecology
Leicester Royal Infirmary
Leicester
UK
Divulgaciones
JCK is an author of a reference cited in this topic.
Frederique van Dunné, MD, PHD, FRANZCOG
Obstetrician
Erasmus Medical Center
Rotterdam
The Netherlands
Divulgaciones
FVD declares that he has no competing interests.
Agradecimiento de los revisores por pares
Los temas de BMJ Best Practice se actualizan de forma continua de acuerdo con los desarrollos en la evidencia y en las guías. Los revisores por pares listados aquí han revisado el contenido al menos una vez durante la historia del tema.
Divulgaciones
Las afiliaciones y divulgaciones de los revisores por pares se refieren al momento de la revisión.
Referencias
Artículos principales
European Society of Human Reproduction and Embryology (ESHRE). Guideline on the management of recurrent pregnancy loss. Feb 2023 [internet publication].Texto completo
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012 Nov;98(5):1103-11. Resumen
Royal College of Obstetricians and Gynaecologists. Recurrent miscarriage: green-top guideline no. 17. Jun 2023 [internet publication].Texto completo Resumen
Jauniaux E, Farquharson RG, Christiansen OB, et al. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006 Sep;21(9):2216-22.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Folletos para el paciente
Bacterial vaginosis
Polycystic ovary syndrome
Más Folletos para el paciente
Inicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad